|Bid||22.59 x 800|
|Ask||57.77 x 800|
|Day's range||55.56 - 58.00|
|52-week range||46.93 - 93.80|
|Beta (5Y monthly)||1.19|
|PE ratio (TTM)||N/A|
|Earnings date||08 Mar 2022 - 14 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||93.20|
Insiders who bought US$4.5m worth of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) stock in the last year have seen...
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 42.86% and 8.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SANTA BARBARA, Calif., May 09, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.